531752 Stock Overview
Engages in the trading of shares and securities. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Biogen Pharmachem Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1.19 |
| 52 Week High | ₹1.79 |
| 52 Week Low | ₹0.98 |
| Beta | -0.33 |
| 1 Month Change | -4.03% |
| 3 Month Change | -9.16% |
| 1 Year Change | -10.53% |
| 3 Year Change | 101.69% |
| 5 Year Change | 440.91% |
| Change since IPO | 120.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531752 | IN Capital Markets | IN Market | |
|---|---|---|---|
| 7D | -2.5% | -2.6% | -2.5% |
| 1Y | -10.5% | 62.0% | 17.9% |
Return vs Industry: 531752 underperformed the Indian Capital Markets industry which returned 62% over the past year.
Return vs Market: 531752 underperformed the Indian Market which returned 17.9% over the past year.
Price Volatility
| 531752 volatility | |
|---|---|
| 531752 Average Weekly Movement | 4.6% |
| Capital Markets Industry Average Movement | 6.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 531752 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 531752's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Niraj Vaghela | www.biogenpharma.life |
Biogen Pharmachem Industries Limited engages in the trading of shares and securities. The company was formerly known as Sun Techno Overseas Limited and changed its name to Biogen Pharmachem Industries Limited in March 2021. Biogen Pharmachem Industries Limited was incorporated in 1995 and is based in Rajkot, India.
Biogen Pharmachem Industries Limited Fundamentals Summary
| 531752 fundamental statistics | |
|---|---|
| Market cap | ₹763.55m |
| Earnings (TTM) | -₹3.52m |
| Revenue (TTM) | n/a |
-53.1x
P/S Ratio-220.7x
P/E RatioIs 531752 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531752 income statement (TTM) | |
|---|---|
| Revenue | -₹14.62m |
| Cost of Revenue | ₹0 |
| Gross Profit | -₹14.62m |
| Other Expenses | -₹11.10m |
| Earnings | -₹3.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0054 |
| Gross Margin | 100.00% |
| Net Profit Margin | 24.07% |
| Debt/Equity Ratio | 0% |
How did 531752 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 14:19 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Biogen Pharmachem Industries Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|